Trial intelligence / Profile preview

Treatment of Patients Suffering from Tumour Cachexia with Dronabinol or Placebo

2007-002968-10Phase 2Terminated

Sponsor
Department of Medicine I, Clinical Dep. f. Oncology, University Hospital,
Start
Oct 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in cancer anorexia-cachexia syndrome (CACS) comparing dronabinol with placebo (2 arms). Primary endpoint: weight change. Started Oct 2007; status: terminated.

02

Drugs

dronabinol
03

Conditions

cancer anorexia-cachexia syndrome (CACS)

Beyond the preview

Go deeper on 2007-002968-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-002968-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call